Global Pharmaceuticals & Biotech Breakout Stocks

Corcept Therapeutics

Market Cap: US$10.0b

A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Avantor

Market Cap: US$9.7b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Kiniksa Pharmaceuticals International

Market Cap: US$6.3b

A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.

Forte Biosciences

Market Cap: US$1.9b

Operates as a clinical-stage biopharmaceutical company in the United States.

Bausch Health Companies

Market Cap: US$1.7b

Operates as a diversified specialty pharmaceutical and medical device company.

Gansu Longshenrongfa Pharmaceutical IndustryLTD

Market Cap: CN¥4.2b

Researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally.

ACRO Biomedical

Market Cap: NT$15.0b

Develops medical-grade regenerative biomaterials in Taiwan, Vietnam, and internationally.

iX Biopharma

Market Cap: S$550.0m

A specialty pharmaceutical and nutraceutical company, develops, manufactures, and commercializes therapies for the treatment of acute and breakthrough pain, and other health conditions in Singapore, the United States, China, and Australia.

GlaxoSmithKlineE

Market Cap: ج.م20.0b

Engages in production of pharmaceutical chemicals.

Agenus

Market Cap: US$296.7m

A clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally.

Anika Therapeutics

Market Cap: US$241.8m

A joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally.

Thor Medical

Market Cap: NOK 1.6b

Produces and supplies alpha-particle emitters for cancer therapy in Norway.

Entera Bio

Market Cap: US$147.9m

A clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally.

Medico Remedies

Market Cap: ₹4.0b

Develops, manufactures, and sells pharmaceutical and nutraceutical products in India.

Intravenous Infusions

Market Cap: GH₵236.0m

A pharmaceutical company, engages in the manufacturing and marketing of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region.

Devonian Health Group

Market Cap: CA$25.7m

Operates as a clinical stage biopharmaceutical corporation with novel therapeutic approaches targeting unmet medical needs in Canada and Internationally.

Blueberries Medical

Market Cap: CA$9.9m

A consumer science company, engages in the commercialization of medicinal cannabis and related products in Colombia.

Panacea Life Sciences Holdings

Market Cap: US$5.4m

Operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals.

Maple Leaf Green World

Market Cap: US$1.2m

Does not have significant operations.

Affymax

Market Cap: US$74.5k

Does not have significant operations.

ObsEva

Market Cap: US$11.7k

A biopharmaceutical company, focuses on the development of novel therapies to improve women’s reproductive health.